Salt Lake City-based Amedica has developed a Silicon Nitride technology for orthopedic and spine implants that looks to promote bone on-growth and be a safe alternative to PEEK and titanium for interbody fusion.
GE’s capital investment will help fund this and other device developments geared toward improving patient care and outcomes, according to the report.
More Articles on Spine Devices:
38 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
TranS1 Pays $6M to Settle Federal Investigation
Orthofix Launches CONSTRUX Spine Implant
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
